Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition
Abstract Background Philadelphia chromosome negative myeloproliferative neoplasms (MPNs), including essential thrombocythemia, polycythemia vera, and myelofibrosis, have severe function‐limiting symptom burden that is experienced by the majority of patients. Previous studies have suggested that depr...
Main Authors: | Leslie Padrnos, Robyn Scherber, Holly Geyer, Blake T. Langlais, Amylou C. Dueck, Heidi E. Kosiorek, Zhenya Senyak, Matthew Clark, Michael Boxer, Mary Cotter, Claire Harrison, Cynthia Stonnington, Yonas Geda, Ruben Mesa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3380 |
Similar Items
-
The Power of Extracellular Vesicles in Myeloproliferative Neoplasms: “Crafting” a Microenvironment That Matters
by: Lucia Catani, et al.
Published: (2021-09-01) -
Disease-Specific Derangement of Circulating Endocannabinoids and <i>N</i>-Acylethanolamines in Myeloproliferative Neoplasms
by: Dorian Forte, et al.
Published: (2020-05-01) -
Synergic Crosstalk between Inflammation, Oxidative Stress, and Genomic Alterations in BCR–ABL-Negative Myeloproliferative Neoplasm
by: Alessandro Allegra, et al.
Published: (2020-10-01) -
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
by: Tarinee Rungjirajittranon, et al.
Published: (2019-02-01) -
Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms
by: Moysés Antonio Porto-Soares, et al.
Published: (2020-07-01)